Works matching IS 17427835 AND DT 2023 AND VI 133 AND IP 5
Results: 15
Eugenol delays the onset of ouabain‐induced ventricular cardiac arrhythmias in guinea pigs.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 565, doi. 10.1111/bcpt.13941
- By:
- Publication type:
- Article
Development and validation of an automated microfluidic perfusion platform for parallelized screening of compounds in vitro.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 535, doi. 10.1111/bcpt.13940
- By:
- Publication type:
- Article
The long non‐coding RNA maternally expressed 3‐micorRNA‐15a‐5p axis is modulated by melatonin and prevents nucleus pulposus cell inflammation and apoptosis.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 603, doi. 10.1111/bcpt.13939
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics and safety of LPM3480392 in two phase I clinical trials in healthy Chinese male subjects.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 592, doi. 10.1111/bcpt.13937
- By:
- Publication type:
- Article
A five‐pronged critique of 'Serotonin syndrome—A focused review'.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 548, doi. 10.1111/bcpt.13933
- By:
- Publication type:
- Article
Disease‐modifying therapies in multiple sclerosis: A focused review of rituximab.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 550, doi. 10.1111/bcpt.13932
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant/TS‐142 in healthy Japanese participants following single/multiple dosing: Randomized, double‐blind, placebo‐controlled phase‐1 studies
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 576, doi. 10.1111/bcpt.13930
- By:
- Publication type:
- Article
Kappa opioid receptor agonist U50,488 inhibits dopamine more in caudal than rostral nucleus accumbens core.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 526, doi. 10.1111/bcpt.13929
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 437, doi. 10.1111/bcpt.13754
- Publication type:
- Article
Computational and structural insights into the pre‐ and post‐hydrolysis states of bovine multidrug resistance‐associated protein 1.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 508, doi. 10.1111/bcpt.13871
- By:
- Publication type:
- Article
Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 496, doi. 10.1111/bcpt.13838
- By:
- Publication type:
- Article
Illuminating the monoamine transporters: Fluorescently labelled ligands to study dopamine, serotonin and norepinephrine transporters.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 473, doi. 10.1111/bcpt.13827
- By:
- Publication type:
- Article
The human LAT1–4F2hc (SLC7A5–SLC3A2) transporter complex: Physiological and pathophysiological implications.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 459, doi. 10.1111/bcpt.13821
- By:
- Publication type:
- Article
Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 439, doi. 10.1111/bcpt.13810
- By:
- Publication type:
- Article
Betaine—The dark knight of the brain.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 5, p. 485, doi. 10.1111/bcpt.13839
- By:
- Publication type:
- Article